News

The European Investment Bank (EIB) has taken a further step forward in fostering innovation in the Spanish and European pharmaceutical sector. By granting a €120 MM loan to Almirall…
Read More...

Clinigen Group plc announces that its Commercial Medicines business has signed an exclusive agreement with Accord Healthcare (‘Accord’) to supply and distribute Clinigen’s speciality…
Read More...

Prestige BioPharma (herein, Prestige) announced positive top-line results from a Phase III global clinical trial (Troika) evaluating the efficacy, safety, and pharmacokinetics (PK) of…
Read More...

Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule…
Read More...

GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases,…
Read More...

Arrowhead Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ARO-APOC3 for the treatment of familial chylomicronemia…
Read More...

Sanofi and Regeneron Pharmaceuticals announced that a Phase 2 proof-of-concept trial evaluating the investigational IL-33 antibody REGN3500 (SAR440340) met the primary endpoint of…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada)  announced that Lynparza (olaparib) has been approved in Japan as a…
Read More...

Amgen and the University of Washington's Institute for Protein Design (IPD), which is revolutionizing its field of science by creating custom-designed proteins from scratch to improve…
Read More...

Gilead Sciences, Inc. and Nurix Therapeutics, Inc., a company discovering drugs that harness the body’s natural process to control protein levels, today announced a global strategic…
Read More...

Pfizer Inc. and Array BioPharma Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical…
Read More...

WuXi Biologics announced that it planned to expand the new state-of-the-art integrated biologics conjugation solution center to include commercial manufacturing in Wuxi city, China.…
Read More...

Axovant Gene Therapies Ltd.  announces that it has signed a strategic partnership with Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) for preferred…
Read More...

Gamida Cell Ltd. and Lonza announced that the companies have entered into a strategic manufacturing agreement. The agreement provides for the future commercial production after…
Read More...

Ricoh Company, Ltd., (Tokyo, Japan) announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc., (Baltimore, Maryland, USA), to develop innovative…
Read More...

Bristol-Myers Squibb Company and Catalent, Inc. announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and…
Read More...

Ultragenyx Pharmaceutical, Inc. and Arcturus Therapeutics Holdings Inc. announced that they have expanded their collaboration to discover and develop mRNA, DNA and siRNA therapeutics…
Read More...

Cognizant announced it has agreed to acquire Zenith Technologies, a privately-held life sciences manufacturing technology services company headquartered in Cork, Ireland. Zenith…
Read More...

Ironwood Pharmaceuticals, Inc. and Allergan plc announced positive topline data from a Phase IIIb clinical trial evaluating LINZESS (linaclotide) 290 mcg on multiple abdominal symptoms…
Read More...

ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics and a market leader in automated cellular processing, today announced that it has received Health Canada approval of…
Read More...